CELC Company Profile and Key Details

Q: Who are the executives of CELC?

Ms. Vicky HahneChief Financial OfficerMr. Igor Gorbatchevsky M.D.Chief Medical OfficerMr. Brian F. SullivanCo-Founder, Chairman & Chief Executive OfficerMr. Eric LindquistChief Bus. OfficerDr. John R. MacDonald Dabt, Ph., Ph.D.Senior Vice President of R&DMs. Sheri SmithActing Head of Clinical OperationsDr. Lance G. Laing Ph.D.Co-Founder, Chief Science Officer, Vice President, Sec. & Director

NASDAQ : CELC

Celcuity

$144.98

19.33+15.38%

At Close 4:00 PM

62.58

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Celcuity Inc. (CELC) stock surged +15.38%, trading at $144.98 on NASDAQ, up from the previous close of $125.65. The stock opened at $142.81, fluctuating between $137.03 and $151.02 in the recent session.

Stock Snapshot

125.65

Prev. Close

7.01B

Market Cap

137.03

Day Low

-38.35

P/E Ratio

-3.78

EPS (TTM)

-1.87

Cash Flow per Share

142.81

Open

48.34M

Number of Shares

151.02

Day High

78.39%

Free Float in %

4.84

Book Value

3.8M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 04, 2026	142.12	151.02	136.06	144.98	3.85M
Apr 30, 2026	118.91	121.57	116.50	121.35	674.83K
Apr 29, 2026	122.00	122.00	117.00	119.00	737.93K
Apr 28, 2026	125.68	127.04	119.71	120.07	701.94K
Apr 27, 2026	121.70	129.09	121.58	125.68	975.39K
Apr 23, 2026	122.00	122.98	112.00	113.56	792.05K
Apr 22, 2026	126.30	128.28	119.87	122.42	490.12K
Apr 21, 2026	119.64	127.18	117.56	126.07	751.29K
Apr 20, 2026	122.37	122.44	119.01	120.09	926.48K
Apr 17, 2026	125.66	125.66	121.46	122.46	482.69K
Apr 16, 2026	122.99	127.34	122.47	125.25	1.1M
Apr 14, 2026	119.99	122.92	119.23	120.85	660.82K
Apr 13, 2026	117.75	121.90	117.40	120.40	566.76K
Apr 10, 2026	125.00	125.00	115.50	117.14	618.79K
Apr 09, 2026	116.80	124.64	115.68	124.64	1.12M
Apr 08, 2026	118.00	118.90	114.89	116.94	554.72K
Apr 07, 2026	113.43	116.11	112.51	115.56	608.68K
Apr 06, 2026	112.54	115.08	112.54	114.22	821.11K
Apr 02, 2026	109.20	114.65	109.20	112.63	501.39K
Apr 01, 2026	115.60	117.91	112.39	112.93	736.58K

Contact Details

Minneapolis, MN 55446

United States

https://www.celcuity.com 763 392 0767

About Company

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Stock Peers

ARGX

27.59+3.52%

argenx SE$811.09 REGN

7.79+1.11%

Regeneron Pharmaceuticals, Inc.$709.21 UTHR

10.82+1.90%

United Therapeutics Corporation$581.22 MDGL

4.94002+0.96%

Madrigal Pharmaceuticals, Inc.$518.66 VRTX

5.93+1.40%

Vertex Pharmaceuticals Incorporated$429.85 PRAX

13.41+4.14%

Praxis Precision Medicines, Inc.$337.61 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

1.815+0.61%

Alnylam Pharmaceuticals, Inc.$297.93 KRYS

20.91+7.86%

Krystal Biotech, Inc.$286.95 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Celcuity Inc. (CELC) stock price?

Celcuity Inc. (NASDAQ: CELC) stock price is $144.98 in the last trading session. During the trading session, CELC stock reached the peak price of $151.02 while $137.03 was the lowest point it dropped to. The percentage change in CELC stock occurred in the recent session was 15.38% while the dollar amount for the price change in CELC stock was $19.33.

CELC's industry and sector of operation?

The NASDAQ listed CELC is part of Biotechnology industry that operates in the broader Healthcare sector. Celcuity Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CELC?

Ms. Vicky Hahne
Chief Financial Officer
Mr. Igor Gorbatchevsky M.D.
Chief Medical Officer
Mr. Brian F. Sullivan
Co-Founder, Chairman & Chief Executive Officer
Mr. Eric Lindquist
Chief Bus. Officer
Dr. John R. MacDonald Dabt, Ph., Ph.D.
Senior Vice President of R&D
Ms. Sheri Smith
Acting Head of Clinical Operations
Dr. Lance G. Laing Ph.D.
Co-Founder, Chief Science Officer, Vice President, Sec. & Director

How CELC did perform over past 52-week?

CELC's closing price is 1,424.5% higher than its 52-week low of $9.51 where as its distance from 52-week high of $151.02 is -4%.

How many employees does CELC have?

Number of CELC employees currently stands at 87.

Link for CELC official website?

Official Website of CELC is: https://www.celcuity.com

How do I contact CELC?

CELC could be contacted at phone 763 392 0767 and can also be accessed through its website. CELC operates from 16305–36th Avenue North, Minneapolis, MN 55446, United States.

How many shares of CELC are traded daily?

CELC stock volume for the day was 3.8M shares. The average number of CELC shares traded daily for last 3 months was 737.13K.

What is the market cap of CELC currently?

The market value of CELC currently stands at $7.01B with its latest stock price at $144.98 and 48.34M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	87
Beta	0.42
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	87
Beta	0.42
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

CELC Company Profile and Key Details

Celcuity

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways